Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Niacin.php on line 2
Niacin
LE WE PMID CA
Niacin3304Niacin

Avasimibe

Colesevelam

Ezetimibe

Fibrate

GPR109A HM74A

Implitapide

Laropiprant

Lipoprotein (Dyslipoproteinemia Hyperlipoproteinemia)

Lipoprotein (HDL)

Lipoprotein a

Niacin

Prostaglandin D2

Statin

Torcetrapib

2004  
1
New perspectives on the use of niacin in the treatment of lipid disorders.
[15078639] Arch Intern Med 164(7): 697-705 (2004)
2009  
2
Management of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacin.
[19436666] Vasc Health Risk Manag 5(1): 31-43 (2009)
2008  
3
Targeting multiple dyslipidemias with fixed combinations--focus on extended release niacin and simvastatin.
[19183748] Vasc Health Risk Manag 4(5): 1001-9 (2008)
2010  
4
Critical appraisal of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia.
[20421916] Ther Clin Risk Manag 6(-): 183-90 (2010)
2002  
5
2002  
6
Niacin-based therapy for dyslipidemia: past evidence and future advances.
[12240703] Am J Manag Care 8(12 Suppl): S315-22 (2002)
2003  
7
Niacin as a component of combination therapy for dyslipidemia.
[12934785] Mayo Clin Proc 78(6): 735-42 (2003)
2008  
8
Of mice and men: blowing away the cobwebs from the mechanism of action of niacin on HDL metabolism.
[18946055] Arterioscler Thromb Vasc Biol 28(11): 1892-5 (2008)
2009  
9
Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia.
[19627285] Br J Pharmacol 158(2): 429-41 (2009)
2006  
10
2011  
11
The resurgence of niacin: from nicotinic acid to niaspan/laropiprant.
[21809737] Isr Med Assoc J 13(6): 368-74 (2011)
2009  
12
Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia.
[20016845] Vasc Health Risk Manag 5(-): 901-8 (2009)
2007  
13
Prolonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS study.
[17969377] Vasc Health Risk Manag 3(4): 467-79 (2007)
2009  
14
The mechanism and mitigation of niacin-induced flushing.
[19691622] Int J Clin Pract 63(9): 1369-77 (2009)
2010  
15
Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia.
[21701618] Drug Healthc Patient Saf 2(-): 61-71 (2010)
2011  
16
Extended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parameters.
[22084607] Clin Med Insights Cardiol 5(-): 85-101 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Niacin.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Niacin.php on line 92